A detailed history of Sanctuary Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Sanctuary Advisors, LLC holds 20,987 shares of MRNA stock, worth $684,176. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,987
Previous 18,331 14.49%
Holding current value
$684,176
Previous $754 Million 14.3%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$36.85 - $63.93 $97,873 - $169,798
2,656 Added 14.49%
20,987 $861 Million
Q3 2024

Nov 25, 2024

BUY
$63.64 - $125.14 $1.17 Million - $2.29 Million
18,331 New
18,331 $754 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $12.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sanctuary Advisors, LLC Portfolio

Follow Sanctuary Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanctuary Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanctuary Advisors, LLC with notifications on news.